MPM Focus Area

Personalized therapeutics for genetically defined cancer

About

Our Focus

We are a world-leading biotechnology investment firm with three decades of experience creating and investing in innovative biotechnology companies seeking to deliver transformative therapies to patients in the areas of highest unmet medical need. At our core, we are company creators. Our dedicated team of Entrepreneurs provide deep domain expertise in research and development, intellectual property, clinical strategy and commercialization, which we believe is crucial to successful company building.

MPM manages early-stage venture funds and, its affiliate manager, BioImpact Capital manages private/public impact funds and a public equities fund. Together, we convert science into therapeutics to reach the patients that need them most.

Focus Area

Investments

Exit Type

Role

Location

  1. 2022
  2. 2021
  3. 2020
  4. 2019
  5. 2018
  6. 2017
  7. 2016
  8. 2015
  9. 2014